炎症性肠病药物治疗的肿瘤风险

Risk of malignancy in the drug therapy for inflammatory bowel disease

近年来炎症性肠病(inflammatory bowel disease,IBD)治疗相关的肿瘤风险越来越受到关注,关于免疫抑制剂及生物制剂对肿瘤的影响,不同研究报道结果尚不一致。本文就应用免疫抑制剂和生物制剂可能带来的肿瘤风险及预防和筛查的策略研究进展作一概述。

People have paid more and more attention to the tumor risk in the drug therapy of inflammatory bowel disease （IBD）. However, studies about the effect of drugs such as immunosuppressants and biological agents on tumor have different results. Here, we will mainly review the tumor risk of immunosuppressants and biological agents and the strategy of prevention and screening.